renal and visceral disease, late deaths (within two years) are largely attributable to cerebrovascular, and to a lesser extent cardiac, events. 2 The addition of cytotoxic agents to corticosteroids may be more efficacious than steroids alone in treatment of PAN4; this approach, or the use of higher dose immunosuppressive treatment, should be considered for patients with PAN who have evidence of cerebrovascular disease. The early recognition and appropriate treatment of PAN significantly improves prognosis;5 our case, and the frequent deaths from cerebrovascular disease in PAN, suggests that cerebral involvement in this condition requires further attention and may merit more aggressive treatment.
Improved renal function indicates a good renovascular response to immunosuppressive treatment. In contrast, there were repeated further neurological events recorded as cerebral infarcts. As far as we know this variable response between the cerebral and renal circulations has not been described previously. 4 Comparison of the distribution of T cell subsets in the peripheral blood (PB) and synovial fluid (SF). Values are given as means (SD) 7 Clinical status and laboratory findings of the patient stabilised by the 19th week ofgestation. During the 20th week of gestation circulating immune complexes and TAT increased to 15-9 ng/ml (normal 10-0) and 21-8 ng/ml (normal <8-3) respectively (figure). Retardation of placental growth was recognised by echogram. Therefore, prednisolone was increased to 30 mg/day and plasmapheresis was carried out three times during the next two weeks. The TAT concentration, however, increased beyond 60 ng/ml and retardation of fetal growth was again detected during the 23rd week of gestation. Fetal distress was noted during the 26th week of gestation, and 
